Deans' stroke musings: In Stroke, When Is a Good Outcome Good Enough?

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, April 10, 2022

In Stroke, When Is a Good Outcome Good Enough?

Very simple, when your survivor declares it good enough without your intervention of trying to force your fucking tyranny of low expectations on your patients.

In Stroke, When Is a Good Outcome Good Enough?

Lee H. Schwamm, M.D.

In this issue of the Journal, Yoshimura and colleagues¹ report the favorable results of a well-conducted randomized trial comparing mechanical thrombectomy (endovascular therapy) with medical care in patients with large-vessel occlusion and large cerebral infarctions. Previous trials of endovascular therapy in selected populations of patients with small and medium-sized strokes have shown beneficial treatment effects, thereby setting the stage for randomized trials of endovascular therapy in patients with large infarctions.² Neurologists have been reluctant to perform endovascular therapy in patients with large infarctions because of the putative risk of bleeding into the infarction and the likelihood that outcomes would be . . .